Clinical trial of ShatPlus Advance in COVID 19 disease
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/06/034131
- Lead Sponsor
- BVG Life Sciences Ltd BVG Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1.Age :18- 60 years (Both sex)
2.Confirmed COVID 19 diseases patient with positive RT-PCR
3.Mild to moderate disease (NEWS score <7) with or without comorbidity
4.Patients willing to provide consent and follow up for study duration
1.Patients with compromised immunity, autoimmune disease or self-reports HIV or syphilis infection
2.Proves to be unfit for the study as per the investigatorâ??s discretion
3.Pregnant or lactating women
4.Requiring supplemental oxygen and ICU admission at screening
5.Known case of comorbidity which is uncontrolled and which in investigator discretion finds patients not suitable for the trial participation
6.Any other medical condition like History of MI, Epileptic episodes finding patients not fit for trial participation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method